Journal of child and adolescent psychopharmacology

Keyphrases

Publications

volume 34, number 3, 2024

Gail A Bernstein, Maroof H Khan, Rebecca L Freese, Cindy Manko, Melissa Silverman, Sana Ahmed, Bahare Farhadian, Meiqian Ma, Margo Thienemann, Tanya K Murphy, Jennifer Frankovich
Psychometric Properties of the PANS 31-Item Symptom Rating Scale. Journal of child and adolescent psychopharmacology 34 (3) (2024)
Gail A Bernstein, Maroof H Khan, Rebecca L Freese, Cindy Manko, Melissa Silverman, Sana Ahmed, Bahare Farhadian, Meiqian Ma, Margo Thienemann, Tanya K Murphy, Jennifer Frankovich
Psychometric Properties of the PANS 31-Item Symptom Rating Scale. Journal of child and adolescent psychopharmacology 34 (3) (2024)
Daniel Zhu, Julie M Zito, James F Gardner, Heather A Young, Scott Quinlan, Angelo Elmi
Stimulant Patterns, Alone or with Other Psychotropic Classes, in Medicaid-Insured Youth Continuously Enrolled for 3-8 Years. Journal of child and adolescent psychopharmacology 34 (3) (2024)
Gail A Bernstein, Maroof H Khan, Rebecca L Freese, Cindy Manko, Melissa Silverman, Sana Ahmed, Bahare Farhadian, Meiqian Ma, Margo Thienemann, Tanya K Murphy, Jennifer Frankovich
Psychometric Properties of the PANS 31-Item Symptom Rating Scale. Journal of child and adolescent psychopharmacology 34 (3) (2024)

volume 34, number 4, 2024

Raman Baweja, Stephen V Faraone, Ann C Childress, Margaret Danielle Weiss, Sandra K Loo, Timothy E Wilens, James G Waxmonsky
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Raman Baweja, Stephen V Faraone, Ann C Childress, Margaret Danielle Weiss, Sandra K Loo, Timothy E Wilens, James G Waxmonsky
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Aaron M Silverman, Mikaela K Dimick, Jessica S Barton, Eric A Youngstrom, Benjamin I Goldstein
Comparing Symptoms of Major Depression in Youth with Confirmed Versus Suspected Bipolar Disorder. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Paul E Croarkin
From the Editor-in-Chief's Desk: Precision Classification and Treatment of Early Life Mood Disorders for Improved Outcomes. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Salayna Abdallah, Emma Church, Jennifer B Levin, Amarpreet Chela, Molly McVoy
Short- and Long-Term Outcomes of Suboptimal Medication Adherence in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Literature Review. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Salayna Abdallah, Emma Church, Jennifer B Levin, Amarpreet Chela, Molly McVoy
Short- and Long-Term Outcomes of Suboptimal Medication Adherence in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Literature Review. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Corrie Harris, Mst Sharmin Akter Sumy, Yana B Feygin, Heather Huxol, Ademilola Tejuoso, Theresa Kluthe, Scott Bickel
Changes in Psychiatric Medication Use During the COVID-19 Pandemic in a Pediatric Long-Term Care Facility. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Raman Baweja, Stephen V Faraone, Ann C Childress, Margaret Danielle Weiss, Sandra K Loo, Timothy E Wilens, James G Waxmonsky
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Raman Baweja, Stephen V Faraone, Ann C Childress, Margaret Danielle Weiss, Sandra K Loo, Timothy E Wilens, James G Waxmonsky
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Salayna Abdallah, Emma Church, Jennifer B Levin, Amarpreet Chela, Molly McVoy
Short- and Long-Term Outcomes of Suboptimal Medication Adherence in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Literature Review. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Salayna Abdallah, Emma Church, Jennifer B Levin, Amarpreet Chela, Molly McVoy
Short- and Long-Term Outcomes of Suboptimal Medication Adherence in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Literature Review. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Paul E Croarkin
From the Editor-in-Chief's Desk: Precision Classification and Treatment of Early Life Mood Disorders for Improved Outcomes. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Ning Lyu, Paul J Rowan, Susan Abughosh, Tyler J Varisco, Ying Lin, Hua Chen
Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Salayna Abdallah, Emma Church, Jennifer B Levin, Amarpreet Chela, Molly McVoy
Short- and Long-Term Outcomes of Suboptimal Medication Adherence in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Literature Review. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Ning Lyu, Paul J Rowan, Susan Abughosh, Tyler J Varisco, Ying Lin, Hua Chen
Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Corrie Harris, Mst Sharmin Akter Sumy, Yana B Feygin, Heather Huxol, Ademilola Tejuoso, Theresa Kluthe, Scott Bickel
Changes in Psychiatric Medication Use During the COVID-19 Pandemic in a Pediatric Long-Term Care Facility. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Aaron M Silverman, Mikaela K Dimick, Jessica S Barton, Eric A Youngstrom, Benjamin I Goldstein
Comparing Symptoms of Major Depression in Youth with Confirmed Versus Suspected Bipolar Disorder. Journal of child and adolescent psychopharmacology 34 (4) (2024)
Raman Baweja, Stephen V Faraone, Ann C Childress, Margaret Danielle Weiss, Sandra K Loo, Timothy E Wilens, James G Waxmonsky
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care. Journal of child and adolescent psychopharmacology 34 (4) (2024)

volume 34, number 5, 2024

Joshua J Schwartz, Chloe Roske, Qi Liu, Russell H Tobe, Benjamin A Ely, Vilma Gabbay
C-Reactive Protein Does Not Predict Future Depression Onset in Adolescents: Preliminary Findings from a Longitudinal Study. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Joshua J Schwartz, Chloe Roske, Qi Liu, Russell H Tobe, Benjamin A Ely, Vilma Gabbay
C-Reactive Protein Does Not Predict Future Depression Onset in Adolescents: Preliminary Findings from a Longitudinal Study. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Daniel T Radecki, Weining Z Robieson, Mallika Gopalkrishnan, Edward Greenberg, Mohamed Aziz
Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7-17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Joshua J Schwartz, Chloe Roske, Qi Liu, Russell H Tobe, Benjamin A Ely, Vilma Gabbay
C-Reactive Protein Does Not Predict Future Depression Onset in Adolescents: Preliminary Findings from a Longitudinal Study. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Daniel T Radecki, Weining Z Robieson, Mallika Gopalkrishnan, Edward Greenberg, Mohamed Aziz
Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7-17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Yuhan Zhang, Wenxuan Zhang, Enyan Yu
Systematic Review and Meta-Analysis: Pharmacological and Nonpharmacological Interventions for Disruptive Mood Dysregulation Disorder. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Yuhan Zhang, Wenxuan Zhang, Enyan Yu
Systematic Review and Meta-Analysis: Pharmacological and Nonpharmacological Interventions for Disruptive Mood Dysregulation Disorder. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Paul E Croarkin
From the Editor-in-Chief's Desk: Advancing Evidence-Based Treatments for Disruptive Mood Dysregulation Disorder. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Jenni E Farrow, Thomas J Blom, Wan Y Kwok, Kaitlyn E Hardesty, Jeffrey A Mills, Melissa P DelBello
Prevalence and Correlates of Eating Disorder Symptoms in Adolescents with Bipolar I Disorder. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Joshua J Schwartz, Chloe Roske, Qi Liu, Russell H Tobe, Benjamin A Ely, Vilma Gabbay
C-Reactive Protein Does Not Predict Future Depression Onset in Adolescents: Preliminary Findings from a Longitudinal Study. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Joshua J Schwartz, Chloe Roske, Qi Liu, Russell H Tobe, Benjamin A Ely, Vilma Gabbay
C-Reactive Protein Does Not Predict Future Depression Onset in Adolescents: Preliminary Findings from a Longitudinal Study. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Paul E Croarkin
From the Editor-in-Chief's Desk: Advancing Evidence-Based Treatments for Disruptive Mood Dysregulation Disorder. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Jenni E Farrow, Thomas J Blom, Wan Y Kwok, Kaitlyn E Hardesty, Jeffrey A Mills, Melissa P DelBello
Prevalence and Correlates of Eating Disorder Symptoms in Adolescents with Bipolar I Disorder. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Joshua J Schwartz, Chloe Roske, Qi Liu, Russell H Tobe, Benjamin A Ely, Vilma Gabbay
C-Reactive Protein Does Not Predict Future Depression Onset in Adolescents: Preliminary Findings from a Longitudinal Study. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Daniel T Radecki, Weining Z Robieson, Mallika Gopalkrishnan, Edward Greenberg, Mohamed Aziz
Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7-17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies. Journal of child and adolescent psychopharmacology 34 (5) (2024)

volume 34, number 6, 2024

Alison A Tebbett-Mock, Ema Saito, Sunny X Tang, Madeline McGee, Anna R Van Meter
The Mental Health Toll of the COVID-19 Pandemic on Adolescents Receiving Inpatient Psychiatric Treatment. Journal of child and adolescent psychopharmacology 34 (6) (2024)
Alison A Tebbett-Mock, Ema Saito, Sunny X Tang, Madeline McGee, Anna R Van Meter
The Mental Health Toll of the COVID-19 Pandemic on Adolescents Receiving Inpatient Psychiatric Treatment. Journal of child and adolescent psychopharmacology 34 (6) (2024)
Paul E Croarkin
From the Editor-in-Chief's Desk. Journal of child and adolescent psychopharmacology 34 (6) (2024)
Maria Valicenti-McDermott, Erin Rivelis, Rosa Seijo, Lisa Shulman
Diagnosis of Autism in School Age and Adolescence in an Ethnically Diverse Population. Journal of child and adolescent psychopharmacology 34 (6) (2024)
Ahmed Naguy, Saxby Pridmore, Bibi Alamiri
Letter: Paradoxical Sedation on Methylphenidate in a Child with Attention-Deficit/Hyperactivity Disorder. Journal of child and adolescent psychopharmacology 34 (6) (2024)
Ahmed Naguy, Saxby Pridmore, Bibi Alamiri
Letter: Paradoxical Sedation on Methylphenidate in a Child with Attention-Deficit/Hyperactivity Disorder. Journal of child and adolescent psychopharmacology 34 (6) (2024)
Paul E Croarkin
From the Editor-in-Chief's Desk. Journal of child and adolescent psychopharmacology 34 (6) (2024)
Mariken Dinnissen, Andrea Dietrich, Margreet Bierens, Judith H van der Molen, Anne M Verhallen, Wieske A Overbeek, Barbara J van den Hoofdakker, Yvette Roke, Pieter W Troost, Jan K Buitelaar, Pieter J Hoekstra
Long-Term Effectiveness of Off-Label Risperidone Treatment in Children and Adolescents: A Randomized, Placebo-Controlled Discontinuation Study. Journal of child and adolescent psychopharmacology 34 (6) (2024)
Maria Valicenti-McDermott, Erin Rivelis, Rosa Seijo, Lisa Shulman
Diagnosis of Autism in School Age and Adolescence in an Ethnically Diverse Population. Journal of child and adolescent psychopharmacology 34 (6) (2024)
Karim Lkamel, Jalal Assermouh
Letter: Exploring the Relationship Between Smartphone Addiction, Psychological Distress, Stress, and Self-Esteem Among Moroccan High School Students: A Regression Equation Modeling Study. Journal of child and adolescent psychopharmacology 34 (6) (2024)
Karim Lkamel, Jalal Assermouh
Letter: Exploring the Relationship Between Smartphone Addiction, Psychological Distress, Stress, and Self-Esteem Among Moroccan High School Students: A Regression Equation Modeling Study. Journal of child and adolescent psychopharmacology 34 (6) (2024)
Mariken Dinnissen, Andrea Dietrich, Margreet Bierens, Judith H van der Molen, Anne M Verhallen, Wieske A Overbeek, Barbara J van den Hoofdakker, Yvette Roke, Pieter W Troost, Jan K Buitelaar, Pieter J Hoekstra
Long-Term Effectiveness of Off-Label Risperidone Treatment in Children and Adolescents: A Randomized, Placebo-Controlled Discontinuation Study. Journal of child and adolescent psychopharmacology 34 (6) (2024)

volume 34, number 7, 2024

Magdalena Romanowicz
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Journal of Child and Adolescent Psychopharmacology . Journal of child and adolescent psychopharmacology 34 (7) (2024)